John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the FDA: “Under the extraordinary ...

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe. In a time ...

WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical ...

WASHINGTON D.C. – Today, the Biotechnology Innovation Organization (BIO), in partnership with Kearney, a global management consulting firm, released a first-of-its-kind report that assesses the ...

This is the only conference focused specifically on intellectual property in biotechnology, featuring the latest insights from biotech IP experts, as well as networking events designed to promote ...

Here are a few highlights from the policymakers and regulators who spoke at the event. We look forward to seeing you next year!

In accordance with its Bylaws and Articles of Incorporation, the Biotechnology Innovation Organization (BIO) is governed by its Board of Directors. The Full BIO Board of Directors is comprised of all ...

The Biotechnology Innovation Organization (BIO) is the world’s largest trade association representing the life sciences industry. BIO members are leading the research and development of innovative ...

Biotechnology is bringing us climate-smart technologies to recycle carbon, reduce greenhouse gas emissions and strengthen the resilience of agriculture and food production. Explore the resources and ...

Explore how we drive biotechnology innovation. Advancing newer and better medicines, therapeutics, and vaccines is a collective effort that involves an entire ecosystem, not just one person or company ...

Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s ...

Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s ...